Fig. 2
Original OS curve (A) and refitted OS curve (B). OS, Overall Survival; OS-O(K-M), K-M curve of OS in olaparib group; OS-P (K-M), K-M curve of OS in placebo group;OS-O, OS in olaparib group; OS-P, OS in placebo group
Fig. 2 | Cost Effectiveness and Resource Allocation